Peter M. Jaensch, in his blog post Proposed Food Labeling Changes May be Hard for Pharmaceuticals to Swallow, provides a snapshot introduced H.R. 4913–-the Free Speech About Science Act of 2010, which would amend the Food, Drug, and Cosmetic Act (FD&C Act) to expand disease and health-related claims in the labeling of some foods and dietary supplements. The bill would also add a new subsection to FD&C Act to permit certain claims "to diagnose, mitigate, treat, cure, or prevent a specific disease or class of diseases" in labeling for dietary supplements. These changes, Jaensch notes, "would permit food and dietary supplement manufacturers to make claims similar to those typically made for drug products, without subjecting them to the same degree of oversight or requiring the same depth of scientific analysis."
